Long-Term Cardiovascular, Thromboembolic, and Malignancy Safety of Janus Kinase (JAK) Inhibitors in Dermatologic and Rheumatologic Populations: A Narrative Comparative Review

Authors:
  • SRShakira Bou Rolon
    Shakira Bou Rolon
  • AEAndrea N Ortiz Echevarria
    Andrea N Ortiz Echevarria
  • MCMonica Burgos Claudio
    Monica Burgos Claudio
  • EEEdgar A Solis Esquilin
    Edgar A Solis Esquilin
  • PRPedro J Rodriguez Ramirez
    Pedro J Rodriguez Ramirez

Abstract
No abstract available

This publication has 29 references indexed in Scilit: